Gallo EM, Loch DC, Habashi JP, Calderon JF, Chen Y, Bedja D, van Erp C, Gerber EE, Parker SJ, Sauls K, Judge DP, Cooke SK, Lindsay ME, Rouf R, Myers L, Ap Rhys CM, Kent KC, Norris RA, Huso DL, Dietz HC. Angiotensin II-dependent TGF-β signaling contributes to Loeys-Dietz syndrome vascular pathogenesis. J Clin Invest. 2014 Jan 2;124(1):448-60.
Gould RA, Sinha R, Aziz H, Rouf R, Dietz HC 3rd, Judge DP, Butcher J. Multi-scale biomechanical remodeling in aging and genetic mutant murine mitral valve leaflets: insights into Marfan syndrome. PLoS One. September 11, 2012; 7(9):e44639.
Wei H, Bedja D, Koitabashi N, Xing D, Chen J, Fox-Talbot K, Rouf R, Chen S, Steenbergen C, Harmon JW, Dietz HC, Gabrielson KL, Kass DA, Semenza GL. Endothelial expression of hypoxia inducible factor 1 protects the murine heart and aorta from pressure overload by suppression of TGFb signaling. Proceedings of the National Academy of Sciences. March 8, 2012.
Judge DP, Rouf R, Habashi J, Dietz HC. Mitral valve disease in Marfan syndrome and relate disorders. Journal of Cardiovascular Translational Research. August 25, 2011.
Judge DP, Rouf R. Use of genetics in the clinical evaluation and management of heart failure. Current Treatment Options in Cardiovascular Medicine. December 2010; 12(6):566-77.
Blaha MJ, Bansal S, Rouf R, Golden SH, DeFilippis AP, Blumenthal RS. A practical ‘ABCDE’ approach to treating the metabolic syndrome. Mayo Clinic Proceedings. August 2008; 83(8):932-41.
Rouf R, Greytak S, Wooten EC, Wu J, Boltax J, Picard M, Dillman WH, Patten RD, Huggins GS. Increased FOG-2 in failing myocardium disrupts thyroid hormone-dependent SERCA2 gene transcription. Circulation Research. August 29, 2008;102(5):493-501.
Mudd JO, Borlaug BA, Johnston PV, Kral BG, Rouf R, Blumenthal RS, Kwiterovich PO, Jr. BeyondLDL Cholesterol—Defining the role of LDL heterogeneity in coronary artery disease. Journal of American College of Cardiology. October 30, 2007; 50:1735-1741.